New Listing Alert: Cloud DX - Remote Patient Health Innovator

April 15, 2021

Now on the TSX Venture

Cloud DX is a leading competitor in the highly regulated digital healthcare industry. The company provides remote patient monitoring hardware, software, and recurring revenue services in a frictionless, reimbursable transaction model, coupled with a sales strategy that's driving rapid adoption among global healthcare providers.

Furthermore, the company has seen a 700 percent patient increase in patient enrollment in 2020. Cloud DX is also newly listed on the Toronto Stock Exchange Venture under the symbol CDX.

The company combines core competencies in biomedical hardware engineering, cloud-based medical device architecture, algorithm-based result generation, regulatory approval experience and internationally ISO certified quality management. When brought together these create a new category of medical device: the medically accurate, consumer/clinical vital sign platform. The company is a first-mover in the race to combine clinical grade data collection with a consumer-friendly user experience.

"At Cloud DX, our aim is simple. Make healthcare better for everyone," says CEO Robert Kaul.

For more information on Cloud DX Inc. (TSX.V: CDX) please click the request investor info button.

You might also like

Healthcare
Defence Therapeutics: Revolutionizing Immune-Related Therapies with ACCUM Technology

Defence Therapeutics is a Canadian biotech company developing immune-related therapies using their proprietary ACCUM technology.

Healthcare
Investor Alert - Defence Therapeutics: Developing Immune-related Therapies for Cancer Treatment

Defence Therapeutics is a Canadian biotech company developing immune-related therapies for cancer treatment, including cancer vaccines, antibodies, and drug delivery vehicles.

Content Broadcast on: BNN Bloomberg, CNBC, Bloomberg, FOX Business News, BIZTV, Reuters, YouTube and more!